- Home
- CTVA vs BDX Comparison
CTVA vs BDX Comparison
Compare CTVA & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTVA | BDX |
|---|---|---|
| Founded | N/A | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6B | 48.2B |
| IPO Year | 2018 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CTVA | BDX |
|---|---|---|
| Price | $13.72 | $182.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | $72.57 | ★ $196.50 |
| AVG Volume (30 Days) | ★ 9.0M | 1.5M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 5.81% | 2.33% |
| EPS Growth | ★ 23.08 | N/A |
| EPS | ★ 2.80 | 1.59 |
| Revenue | $17,401,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.07 | $2.39 |
| P/E Ratio | ★ $4.40 | $113.43 |
| Revenue Growth | 2.92 | ★ 8.24 |
| 52 Week Low | $11.74 | $140.11 |
| 52 Week High | $90.97 | $213.08 |
Technical Indicators
Market Signals| Indicator | CTVA | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 7.73 | 51.94 |
| Support Level | N/A | $175.20 |
| Resistance Level | $82.95 | $186.99 |
| Average True Range (ATR) | 1.83 | 3.71 |
| MACD | -7.96 | -0.43 |
| Stochastic Oscillator | 2.80 | 54.25 |
Price Performance
Historical ComparisonAbout CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in late 2026. The seeds business will be named Vylor, while the crop protection business will retain the Corteva name and be a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
About BDX Becton Dickinson and Company
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.